HISAMITSU PHARMACEUTICAL CO.,INC.
4530 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 鳥栖市田代大官町４０８番地
- Website:
- https://global.hisamitsu/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
HISAMITSU PHARMACEUTICAL CO., INC. is a leading Japanese company specializing in the development and manufacturing of innovative pharmaceuticals and healthcare products. Established in 1847, the company is renowned for its expertise in transdermal drug delivery systems and topical medications. Hisamitsu’s portfolio includes a range of prescription medicines and over-the-counter products designed to enhance patient care and improve quality of life. Committed to research and development, the company continually seeks to introduce breakthrough therapies while adhering to rigorous quality standards. With a strong global presence, Hisamitsu aims to leverage advanced technology and strategic partnerships to drive growth and address evolving healthcare needs.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-23 08:00 |
Regulatory News Service
確認書
|
Japanese | 9.5 KB | |
| 2025-05-23 07:58 |
Internal Control over Financial Reporting
内部統制報告書－第123期(2024/03/01－2025/02/28)
|
Japanese | 24.0 KB | |
| 2025-05-23 07:55 |
Annual Report
有価証券報告書－第123期(2024/03/01－2025/02/28)
|
Japanese | 1.7 MB | |
| 2025-05-23 07:44 |
Inside Information Statement
臨時報告書
|
Japanese | 28.3 KB | |
| 2024-10-11 08:12 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-10-11 08:08 |
Interim Report
半期報告書－第123期(2024/03/01－2025/02/28)
|
Japanese | 244.4 KB | |
| 2024-07-12 08:12 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-07-12 08:09 |
Quarterly Report
四半期報告書－第123期第1四半期(2024/03/01－2024/05/31)
|
Japanese | 179.7 KB | |
| 2024-05-24 08:14 |
Regulatory News Service
確認書
|
Japanese | 9.5 KB | |
| 2024-05-24 08:12 |
Internal Control over Financial Reporting
内部統制報告書－第122期(2023/03/01－2024/02/29)
|
Japanese | 24.1 KB | |
| 2024-05-24 08:10 |
Annual Report
有価証券報告書－第122期(2023/03/01－2024/02/29)
|
Japanese | 1.7 MB | |
| 2024-05-24 08:05 |
Inside Information Statement
臨時報告書
|
Japanese | 29.5 KB | |
| 2024-01-12 07:06 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-01-12 07:04 |
Quarterly Report
四半期報告書－第122期第3四半期(2023/09/01－2023/11/30)
|
Japanese | 191.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Immuno-Biological Laboratories Co., Ltd. | Japan | 4570 | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN | |
| JCR Pharmaceuticals Co.,Ltd. | Japan | 4552 |